CASI Pharmaceuticals (CASI) Q1 2025 Earnings

31MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.75
-0.52
-0.28
-0.05

Details

Expected EPS
-0.6
Actual EPS
-0.75
Surprise EPS
-0.15
Surprise Percent
+25%

Description

CASI Pharmaceuticals (CASI) has reported earnings of -0.75 per share for Q1 2025.

0 Comments

Share your thoughts